Viking Therapeutics Gains Momentum Following Key Industry Conference

Shares of Viking Therapeutics experienced a significant surge this week, driven by a series of strategic updates and a notable presentation by its CEO at a major healthcare conference. The company’s stock closed at $34.34 on Wednesday, marking an 11.89% single-day gain. This positive movement reflects growing investor confidence amid clinical progress and commercial preparations.

The recent uptick was largely attributed to remarks made by CEO Brian Lian at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. Lian highlighted that strategic interest in the obesity drug market is “broader than visible,” with multiple pharmaceutical firms actively evaluating assets. He noted that companies are weighing whether to invest early in Read more...